Leukotriene B4
- Molecular formula
- C20H32O4
- CAS Number
- 71160-24-2
- IUPAC Name
- 5,6,15-trihydroxyicosa-7,9,11,13-tetraenoic acid
- Molecular Weight
- 336.47g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.0267g/cm3
- Synonyms
- lipoxin-A4
Identification
Interesting Facts About 5,6,15-Trihydroxyicosa-7,9,11,13-tetraenoic Acid
5,6,15-trihydroxyicosa-7,9,11,13-tetraenoic acid, commonly referred to in scientific literature as a member of the group of polyunsaturated fatty acids, presents a fascinating subject of study due to its diverse biological activities.
- Biological Significance: This compound is known to play a role in various physiological processes, including inflammation and cellular signaling. Its structure suggests potential involvement in modulating immune responses.
- Analytical Interest: The hydroxyl groups present in its structure offer sites for potential chemical modifications, making it an intriguing candidate for research in synthetic organic chemistry.
- Source of Inspiration: 5,6,15-trihydroxyicosa-7,9,11,13-tetraenoic acid serves as a precursor for the synthesis of bioactive lipids, which can inspire drug development, especially in targeting chronic diseases.
- Research Applications: Studies have suggested its potential role in cardiovascular health, suggesting that understanding its mechanisms could lead to enhanced therapeutic strategies.
- Natural Occurrence: Found in various biological systems, this compound highlights the importance of omega fatty acids in nutrition and metabolism.
As stated by one influential researcher in the field, "Understanding the intricate details of fatty acid metabolism can unveil new therapeutic targets for a variety of diseases." This emphasizes the potential of 5,6,15-trihydroxyicosa-7,9,11,13-tetraenoic acid not just as a chemical entity but as a vital part of our biochemical landscape.
In conclusion, the exploration of 5,6,15-trihydroxyicosa-7,9,11,13-tetraenoic acid embodies both challenges and opportunities for future research, holding promise for advancements in health and disease management.